Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a Controlled Versus Standard Oxygen Therapy Strategy in ICU Patients With Acute Exacerbation of COPD: A Randomized Controlled Trial

NCT07842510 is registered in ClinicalTrials.gov with Hôpital Universitaire Taher Sfar as lead sponsor.

NCT NCT07842510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07842510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a Controlled Versus Standard Oxygen Therapy Strategy in ICU Patients With Acute Exacerbation of COPD: A Randomized Controlled Trial
Lead sponsor
Hôpital Universitaire Taher Sfar
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2026
Completion date
December 31, 2028
Enrollment
240 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation of copd, chronic obstructive pulmonary disease (copd), controlled oxygen therapy, intensive care unit (icu), mechanical ventilation complication